Brian Suffoletto1, Amy Zeigler2. 1. Department of Emergency Medicine, University of Pittsburgh School of Medicine, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15261, United States. Electronic address: suffbp@upmc.edu. 2. Department of Emergency Medicine, University of Pittsburgh School of Medicine, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15261, United States.
Abstract
BACKGROUND: Nonfatal opioid overdose (OD) is an opportunity to identify patients who may benefit from interventions to reduce repeated overdose (rOD). In this study, we sought to determine risk and protective factors associated with rOD. METHODS: In this retrospective cohort study of 4,155 patients aged 18-64 who presented to one of 16 emergency departments in a single Western Pennsylvania health system between July 2015 and January 2018 for index opioid overdose (iOD) and survived to discharge, we identified demographic and clinical factors association with rOD within one-year. Relative risk of repeated opioid overdose was estimated using adjusted Cox proportional hazard ratios (aHRs). RESULTS: 14.9 % of patients (95 % CI 13.9-16.1) had a rOD, with 29 % occurring within 30 days from iOD. The adjusted hazard of opioid overdose was increased for male patients (aHR = 1.19; 95 % CI 1.01, 1.41), those with pre-iOD diagnoses of anxiety (aHR = 1.41; 95 % CI1.13, 1.77), depression (aHR = 1.44; 95 % CI 1.17, 1.78), substance use disorders (aHR = 1.30; 95 % CI 1.09, 1.55), and alcohol use disorder (aHR = 1.52; 95 % CI 1.02, 2.25). The hazard was lower for individuals prescribed an opioid in the 90 days prior to iOD (aHR = 0.59; 95 % CI 0.37, 0.97) and those admitted to the hospital for iOD (aHR = 0.56; 95 % CI 0.37, 0.86). CONCLUSION: We found that, among ED patients who survive an initial OD, mental health and substance use diagnoses are associated with a higher hazard of repeated overdoses whereas opioids prescriptions and admission are associated with lower hazards.
BACKGROUND:Nonfatal opioid overdose (OD) is an opportunity to identify patients who may benefit from interventions to reduce repeated overdose (rOD). In this study, we sought to determine risk and protective factors associated with rOD. METHODS: In this retrospective cohort study of 4,155 patients aged 18-64 who presented to one of 16 emergency departments in a single Western Pennsylvania health system between July 2015 and January 2018 for index opioid overdose (iOD) and survived to discharge, we identified demographic and clinical factors association with rOD within one-year. Relative risk of repeated opioid overdose was estimated using adjusted Cox proportional hazard ratios (aHRs). RESULTS: 14.9 % of patients (95 % CI 13.9-16.1) had a rOD, with 29 % occurring within 30 days from iOD. The adjusted hazard of opioid overdose was increased for male patients (aHR = 1.19; 95 % CI 1.01, 1.41), those with pre-iOD diagnoses of anxiety (aHR = 1.41; 95 % CI1.13, 1.77), depression (aHR = 1.44; 95 % CI 1.17, 1.78), substance use disorders (aHR = 1.30; 95 % CI 1.09, 1.55), and alcohol use disorder (aHR = 1.52; 95 % CI 1.02, 2.25). The hazard was lower for individuals prescribed an opioid in the 90 days prior to iOD (aHR = 0.59; 95 % CI 0.37, 0.97) and those admitted to the hospital for iOD (aHR = 0.56; 95 % CI 0.37, 0.86). CONCLUSION: We found that, among ED patients who survive an initial OD, mental health and substance use diagnoses are associated with a higher hazard of repeated overdoses whereas opioids prescriptions and admission are associated with lower hazards.
Authors: Kate Smolina; Alexis Crabtree; Mei Chong; Bin Zhao; Mina Park; Christopher Mill; Christian G Schütz Journal: Drug Alcohol Depend Date: 2018-10-25 Impact factor: 4.492
Authors: Marc R Larochelle; Jane M Liebschutz; Fang Zhang; Dennis Ross-Degnan; J Frank Wharam Journal: Ann Intern Med Date: 2015-12-29 Impact factor: 25.391
Authors: Alana M Vivolo-Kantor; Puja Seth; R Matthew Gladden; Christine L Mattson; Grant T Baldwin; Aaron Kite-Powell; Michael A Coletta Journal: MMWR Morb Mortal Wkly Rep Date: 2018-03-09 Impact factor: 17.586
Authors: Stephen Crystal; Molly Nowels; Hillary Samples; Mark Olfson; Arthur Robin Williams; Peter Treitler Journal: Drug Alcohol Depend Date: 2022-01-10 Impact factor: 4.492
Authors: Xinyi Jiang; Gery P Guy; Christopher Dunphy; Cassandra M Pickens; Christopher M Jones Journal: Drug Alcohol Depend Date: 2021-10-30 Impact factor: 4.492
Authors: Leslie A Lenert; Vivienne Zhu; Lindsey Jennings; Jenna L McCauley; Jihad S Obeid; Ralph Ward; Saeed Hassanpour; Lisa A Marsch; Michael Hogarth; Perry Shipman; Daniel R Harris; Jeffery C Talbert Journal: JAMIA Open Date: 2022-06-30
Authors: Umedjon Ibragimov; Russell W Mansfield; Courtney R Yarbrough; Janet R Cummings; Melvin D Livingston; Regine Haardörfer; Stephanie Beane; Monica M Fadanelli; Danielle F Haley; Hannah L F Cooper Journal: Drug Alcohol Depend Date: 2022-02-26 Impact factor: 4.852
Authors: Joshua C Zamora; Hudson R Smith; Elaine M Jennings; Teresa S Chavera; Varun Kotipalli; Aleasha Jay; Stephen M Husbands; Alex Disney; Kelly A Berg; William P Clarke Journal: Pharmacol Res Perspect Date: 2021-12
Authors: Alex S Bennett; Joy Scheidell; Jeanette M Bowles; Maria Khan; Alexis Roth; Lee Hoff; Christina Marini; Luther Elliott Journal: Harm Reduct J Date: 2022-03-04
Authors: Janni Leung; Thomas Santo; Samantha Colledge-Frisby; Tesfa Mekonen; Kate Thomson; Louisa Degenhardt; Jason P Connor; Wayne Hall; Daniel Stjepanović Journal: Pain Med Date: 2022-08-01 Impact factor: 3.637
Authors: Ivan Urits; Anjana Patel; Robbie Zusman; Celina Guadalupe Virgen; Mohammad Mousa; Amnon A Berger; Hisham Kassem; Jai Won Jung; Jamal Hasoon; Alan D Kaye; Omar Viswanath Journal: Psychopharmacol Bull Date: 2020-07-23